tiprankstipranks
Trending News
More News >
Orchid Pharma Limited (IN:ORCHPHARMA)
:ORCHPHARMA
India Market

Orchid Pharma Limited (ORCHPHARMA) Ratios

Compare
0 Followers

Orchid Pharma Limited Ratios

IN:ORCHPHARMA's free cash flow for Q2 2026 was ₹0.32. For the 2026 fiscal year, IN:ORCHPHARMA's free cash flow was decreased by ₹ and operating cash flow was ₹<0.01. See a summary of the company’s cash flow.
Ratios
TTM
Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio
3.35 2.83 3.04 1.35 1.65
Quick Ratio
1.90 1.68 2.03 0.73 0.93
Cash Ratio
0.20 0.07 0.01 0.06 0.02
Solvency Ratio
0.12 0.32 0.33 0.19 0.18
Operating Cash Flow Ratio
0.05 0.07 0.48 0.05 0.38
Short-Term Operating Cash Flow Coverage
0.24 0.45 8.97 0.10 1.55
Net Current Asset Value
₹ 2.56B₹ 3.87B₹ 4.06B₹ -355.48M₹ -655.33M
Leverage Ratios
Debt-to-Assets Ratio
0.16 0.10 0.09 0.27 0.24
Debt-to-Equity Ratio
0.22 0.14 0.12 0.48 0.41
Debt-to-Capital Ratio
0.18 0.12 0.10 0.32 0.29
Long-Term Debt-to-Capital Ratio
0.16 0.09 0.09 0.18 0.24
Financial Leverage Ratio
1.35 1.33 1.33 1.78 1.72
Debt Service Coverage Ratio
1.05 2.53 4.71 0.65 0.63
Interest Coverage Ratio
3.21 5.58 4.64 0.90 -1.01
Debt to Market Cap
0.11 0.04 0.03 0.21 0.23
Interest Debt Per Share
58.37 37.30 31.41 89.24 73.85
Net Debt to EBITDA
3.58 1.06 0.93 2.16 4.24
Profitability Margins
Gross Profit Margin
36.82%38.48%16.62%10.62%41.54%
EBIT Margin
3.87%11.94%13.22%13.14%-4.45%
EBITDA Margin
8.24%15.69%17.33%21.47%11.10%
Operating Profit Margin
5.57%8.80%9.49%4.46%-6.06%
Pretax Profit Margin
2.67%10.79%10.87%8.30%-10.17%
Net Profit Margin
2.33%10.81%11.25%6.96%-0.35%
Continuous Operations Profit Margin
2.33%10.81%11.25%7.97%-10.80%
Net Income Per EBT
87.01%100.19%103.50%83.84%3.43%
EBT Per EBIT
47.95%122.62%114.60%186.21%167.89%
Return on Assets (ROA)
1.10%5.90%5.93%3.78%-0.18%
Return on Equity (ROE)
1.50%7.86%7.88%6.73%-0.30%
Return on Capital Employed (ROCE)
2.99%5.78%6.01%3.48%-3.90%
Return on Invested Capital (ROIC)
2.52%5.61%5.94%2.75%-3.65%
Return on Tangible Assets
1.11%5.96%5.99%3.78%-0.18%
Earnings Yield
0.73%2.51%1.72%2.96%-0.17%
Efficiency Ratios
Receivables Turnover
4.01 3.81 4.09 3.09 3.28
Payables Turnover
3.44 2.55 2.97 3.41 1.95
Inventory Turnover
1.67 1.74 2.58 2.60 1.89
Fixed Asset Turnover
1.10 1.32 1.27 1.08 0.93
Asset Turnover
0.47 0.55 0.53 0.54 0.50
Working Capital Turnover Ratio
3.28 1.75 2.48 4.66 1.98
Cash Conversion Cycle
202.97 162.85 107.80 151.38 116.81
Days of Sales Outstanding
90.97 95.74 89.28 118.04 111.26
Days of Inventory Outstanding
218.07 210.04 141.22 140.27 192.67
Days of Payables Outstanding
106.07 142.93 122.70 106.93 187.12
Operating Cycle
309.04 305.78 230.51 258.31 303.93
Cash Flow Ratios
Operating Cash Flow Per Share
2.27 3.79 26.05 4.49 22.66
Free Cash Flow Per Share
-29.07 -25.81 12.65 -16.31 19.13
CapEx Per Share
31.34 29.60 13.40 20.80 3.53
Free Cash Flow to Operating Cash Flow
-12.79 -6.81 0.49 -3.63 0.84
Dividend Paid and CapEx Coverage Ratio
0.07 0.13 1.94 0.22 6.42
Capital Expenditure Coverage Ratio
0.07 0.13 1.94 0.22 6.42
Operating Cash Flow Coverage Ratio
0.04 0.11 0.93 0.06 0.35
Operating Cash Flow to Sales Ratio
0.01 0.02 0.15 0.03 0.17
Free Cash Flow Yield
-5.70%-3.30%1.14%-4.26%6.71%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
136.86 39.84 58.06 33.77 -596.60
Price-to-Sales (P/S) Ratio
3.19 4.31 6.53 2.35 2.08
Price-to-Book (P/B) Ratio
2.03 3.13 4.58 2.27 1.80
Price-to-Free Cash Flow (P/FCF) Ratio
-17.56 -30.33 87.47 -23.50 14.91
Price-to-Operating Cash Flow Ratio
224.35 206.64 42.47 85.30 12.59
Price-to-Earnings Growth (PEG) Ratio
-2.14 12.87 0.85 -0.01 6.07
Price-to-Fair Value
2.03 3.13 4.58 2.27 1.80
Enterprise Value Multiple
42.25 28.51 38.63 13.10 22.98
Enterprise Value
28.25B 41.24B 54.82B 18.73B 14.28B
EV to EBITDA
42.25 28.51 38.63 13.10 22.98
EV to Sales
3.48 4.47 6.69 2.81 2.55
EV to Free Cash Flow
-19.19 -31.51 89.62 -28.13 18.29
EV to Operating Cash Flow
245.45 214.63 43.51 102.14 15.44
Tangible Book Value Per Share
248.39 246.52 238.71 168.62 158.53
Shareholders’ Equity Per Share
251.47 249.88 241.80 168.72 158.61
Tax and Other Ratios
Effective Tax Rate
0.13 >-0.01 -0.04 0.04 -0.06
Revenue Per Share
160.14 181.78 169.35 163.14 137.09
Net Income Per Share
3.72 19.65 19.06 11.35 -0.48
Tax Burden
0.87 1.00 1.04 0.84 0.03
Interest Burden
0.69 0.90 0.82 0.63 2.29
Research & Development to Revenue
0.01 <0.01 <0.01 <0.01 0.01
SG&A to Revenue
0.00 0.00 0.01 0.01 0.02
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
0.17 0.19 1.37 0.40 -47.39
Currency in INR